ToxSci Advance Access originally published online on October 26, 2005
Toxicological Sciences 2006 89(1):120-134; doi:10.1093/toxsci/kfj017
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A Toxicogenomics Approach to Identify New Plausible Epigenetic Mechanisms of Ochratoxin A Carcinogenicity in Rat
,
* Nestlé Research Center, PO Box 44, Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland; Nephro-Urology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1E 1EH, UK; and Department of Environmental Science and Technology, Imperial College London, London SW7 2AZ, UK
Received August 24, 2005; accepted October 7, 2005
Ochratoxin A (OTA) is a mycotoxin occurring naturally in a wide range of food commodities. In animals, it has been shown to cause a variety of adverse effects, nephrocarcinogenicity being the most prominent. Because of its high toxic potency and the continuous exposure of the human population, OTA has raised public health concerns. There is significant debate on how to use the rat carcinogenicity data to assess the potential risk to humans. In this context, the question of the mechanism of action of OTA appears of key importance and was studied through the application of a toxicogenomics approach. Male Fischer rats were fed OTA for up to 2 years. Renal tumors were discovered during the last 6 months of the study. The total tumor incidence reached 25% at the end of the study. Gene expression profile was analyzed in groups of animals taken in intervals from 7 days to 12 months. Tissue-specific responses were observed in kidney versus liver. For selected genes, microarray data were confirmed at both mRNA and protein levels. In kidney, several genes known as markers of kidney injury and cell regeneration were significantly modulated by OTA. The expression of genes known to be involved in DNA synthesis and repair, or genes induced as a result of DNA damage, was only marginally modulated. Very little or no effect was found amongst genes associated with apoptosis. Alterations of gene expression indicating effects on calcium homeostasis and a disruption of pathways regulated by the transcription factors hepatocyte nuclear factor 4 alpha (HNF4
) and nuclear factor-erythroid 2-related factor 2 (Nrf2) were observed in the kidney but not in the liver. Previous data have suggested that a reduction in HNF4 may be associated with nephrocarcinogenicity. Many Nrf2-regulated genes are involved in chemical detoxication and antioxidant defense. The depletion of these genes is likely to impair the defense potential of the cells, resulting in chronic elevation of oxidative stress in the kidney. The inhibition of defense mechanism appears as a highly plausible new mechanism, which could contribute to OTA carcinogenicity.
Key Words: ochratoxin A; nephrocarcinogenicity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Stemmer, H. Ellinger-Ziegelbauer, H.-J. Ahr, and D. R. Dietrich Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors Am. J. Pathol., October 1, 2009; 175(4): 1686 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cavin, T. Delatour, M. Marin-Kuan, F. Fenaille, D. Holzhauser, G. Guignard, C. Bezencon, D. Piguet, V. Parisod, J. Richoz-Payot, et al. Ochratoxin A-Mediated DNA and Protein Damage: Roles of Nitrosative and Oxidative Stresses Toxicol. Sci., July 1, 2009; 110(1): 84 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Adler, K. Muller, E. Rached, W. Dekant, and A. Mally Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity Carcinogenesis, April 1, 2009; 30(4): 711 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Dieterich, A. Puey, S. Lyn, R. Swezey, A. Furimsky, D. Fairchild, J. C. Mirsalis, and H. H. Ng Gene Expression Analysis Reveals New Possible Mechanisms of Vancomycin-Induced Nephrotoxicity and Identifies Gene Markers Candidates Toxicol. Sci., January 1, 2009; 107(1): 258 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Rached, G. C. Hard, K. Blumbach, K. Weber, R. Draheim, W. K. Lutz, S. Ozden, U. Steger, W. Dekant, and A. Mally Ochratoxin A: 13-Week Oral Toxicity and Cell Proliferation in Male F344/N Rats Toxicol. Sci., June 1, 2007; 97(2): 288 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Stemmer, H. Ellinger-Ziegelbauer, H.-J. Ahr, and D. R. Dietrich Carcinogen-Specific Gene Expression Profiles in Short-term Treated Eker and Wild-type Rats Indicative of Pathways Involved in Renal Tumorigenesis Cancer Res., May 1, 2007; 67(9): 4052 - 4068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Cavin, T. Delatour, M. Marin-Kuan, D. Holzhauser, L. Higgins, C. Bezencon, G. Guignard, S. Junod, J. Richoz-Payot, E. Gremaud, et al. Reduction in Antioxidant Defenses may Contribute to Ochratoxin A Toxicity and Carcinogenicity Toxicol. Sci., March 1, 2007; 96(1): 30 - 39. [Abstract] [Full Text] [PDF]
|
|